STAT1 and metabolic dysfunction-associated steatohepatitis: These findings provided more insight into possible molecular mechanism underlying the association between transcription factors (PPARs) and STAT1 pathway and suggested that genistein might be useful as a hormone replacement therapy to prevent NASH in transgender women.